Malta Pharmaceutical and Medical Goods Expenditure Share (2023)
Malta's Pharmaceutical and Medical Goods Expenditure Share: 22.4 % of current health expenditure in 2023, -0.7pp YoY. Eurostat (HLTH_SHA11_HC), 2016–2023.
Malta (2023)
22.4
% of current health expenditure
-0.7pp YoY
YoY Change
-0.7pp
percentage points
Trend
down
Series length
8
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 22.4 | -0.7pp |
| 2022 | 23.1 | -1.1pp |
| 2021 | 24.2 | -2.8pp |
| 2020 | 27 | +3pp |
| 2019 | 24 | +2.7pp |
| 2018 | 21.3 | -0.3pp |
| 2017 | 21.6 | -0.4pp |
| 2016 | 22 | n/a |
About this Dataset
Malta recorded 22.4 % of current health expenditure in 2023. The latest change was -0.7pp. Across 2016–2023 the series ranges from 21.3 in 2018 to 27 in 2020.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Malta.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Malta. It is published by Eurostat and updated annually.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2023 (8 observations).
The series peaked at 27 % of current health expenditure in 2020 and reached its lowest recorded value of 21.3 in 2018. The latest reading of 22.4 in 2023 represents a change of -0.7pp.